Colon Cancer Blood Test (BeScreened™-CRC) | My Lab ReQuest (sonoraquest.com)
Price is not the selling point for the above mentioned product.
The attraction for the RHY offering is not only effectiveness and accuracy but, drum roll, price. RHY offers a product that, if approved etc, claims to be price attractive to medical professionals and insurers etc. The other product is more expensive but an alternative to the FIT etc.
Something like that.
We are not investing in something that hopes to fill a niche- we are looking to disrupt.
IMHO DYOR
- Forums
- ASX - By Stock
- RHY
- Bescreened 10,000 patient tests /trial
Bescreened 10,000 patient tests /trial, page-13
-
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RHY (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.66M |
Open | High | Low | Value | Volume |
6.3¢ | 6.3¢ | 6.3¢ | $1.89K | 30K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7568 | 6.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.5¢ | 67383 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7568 | 0.063 |
1 | 109999 | 0.062 |
2 | 83639 | 0.060 |
1 | 5000 | 0.056 |
2 | 19091 | 0.055 |
Price($) | Vol. | No. |
---|---|---|
0.065 | 67383 | 4 |
0.066 | 107305 | 1 |
0.067 | 195346 | 2 |
0.070 | 1794 | 1 |
0.071 | 10000 | 1 |
Last trade - 10.53am 10/09/2024 (20 minute delay) ? |
Featured News
RHY (ASX) Chart |